Joy Linton wants to make something crystal clear: the AstraZeneca vaccine is a workhorse jab that is highly effective and saving millions of lives across the world.
She speaks with some authority – and no little interest – as the new chief financial officer of Melbourne-based biotech giant CSL, which makes the controversial vaccine in Australia.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
